Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It mostly presents with fevers and respiratory symptoms that can progress from simple pneumonia to severe acute respiratory distress syndrome (ARDS). It also has significant implications for the cardiovascular care of patients. Troponin, which is a sign of cardiac injury, usually goes up in patients who are hospitalized, and it requires careful consideration. Microvascular activation by cytokines might cause myocardial damage, and it can harm other organs usually involved in COVID-19, such as lungs and kidneys. COVID-19 infection is also associated with venous thromboembolism, arrhythmias, and myocarditis. On the other hand, the cardiovascular care provision might position workers in the healthcare system in vulnerability once they become hosts or vectors for the transmission of coronavirus. In this study, we have investigated the articles on cardiovascular considerations concerning COVID-19 and then introduced the gaps which require more investigation pertinent to patients and healthcare systems.